Cargando…
1730. Real-World Use Of Dalbavancin In A US Tertiary Referral Center
BACKGROUND: Dalbavancin is a lipoglycopeptide with prolonged half-life currently approved for treatment of bacterial skin and soft tissue infections. Off-label uses of dalbavancin include multiple Gram-positive infections requiring long-term antibiotics use. However, clinical data regarding Dalbavan...
Autores principales: | Bhugra, Mudita, Chang, Aaron, Polega, James, Sanctis, Jorgelina De, Vanderhorst, Derek, Hassouna, Habiba |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752461/ http://dx.doi.org/10.1093/ofid/ofac492.1360 |
Ejemplares similares
-
Implementation of COVID-19 Provider Resource Task Force: A provider support initiative during emergency preparedness in a quaternary-care center in western Michigan
por: Moorthy, Vetriselvi, et al.
Publicado: (2020) -
Impact of an inclusive COVID-19 visitation policy on patient satisfaction and visitor safety
por: Nguyen, Chau, et al.
Publicado: (2022) -
Real-World Use – Isavuconazole at a Large Academic Medical Center
por: Hassouna, HabiBA, et al.
Publicado: (2017) -
Effectiveness of Dalbavancin Compared With Standard of Care for the Treatment of Osteomyelitis: A Real-world Analysis
por: Cain, Alexander R, et al.
Publicado: (2021) -
576. Determinants of COVID-19 Vaccine Hesitancy: A Cross-Sectional Study in 3 Communities in the United States and Lebanon
por: Yasmin, Mohamad, et al.
Publicado: (2021)